info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Human Insulin Market Research Report Information By Fusion Type (Analogue Insulin, Traditional Human Insulin, Posterior Fusion), By Type (Metal, Polymer, And Others), By Diabetes Type (Diabetes 1, And Diabetes 2), By Distribution Channels (Hospital Pharmacy, Retail & Online Pharmacy, Neurology Clinics, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) โ€“ Market Forecast Till 2032.


ID: MRFR/Pharma/0445-CR | 117 Pages | Author: Kinjoll Dey| February 2021

Human Insulinย Market Segmentation


Human Insulin Type Outlook (USD Billion, 2018-2030)



  • Analogue Insulin

  • Traditional Human Insulin


Human Insulin Diabetes Type Outlook (USD Billion, 2018-2030)



  • Diabetes 1

  • Diabetes 2


Human Insulin Distribution Channel Outlook (USD Billion, 2018-2030)



  • Hospital Pharmacy

  • Retail & Online Pharmacy


Human Insulin Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)


    • North America Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • North America Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • North America Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • US Outlook (USD Billion, 2018-2030)


    • US Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • US Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • US Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • CANADA Outlook (USD Billion, 2018-2030)


    • CANADA Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • CANADA Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • CANADA Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy





  • Europe Outlook (USD Billion, 2018-2030)






    • Europe Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Europe Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Europe Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy



    • Germany Outlook (USD Billion, 2018-2030)


    • Germany Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Germany Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Germany Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy



    • France Outlook (USD Billion, 2018-2030)


    • France Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • France Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • France Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • UK Outlook (USD Billion, 2018-2030)


    • UK Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • UK Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • UK Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • ITALY Outlook (USD Billion, 2018-2030)


    • ITALY Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • ITALY Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • ITALY Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • SPAIN Outlook (USD Billion, 2018-2030)


    • Spain Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Spain Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Spain Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Rest Of Europe Outlook (USD Billion, 2018-2030)


    • Rest Of Europe Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • REST OF EUROPE Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • REST OF EUROPE Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy





  • Asia-Pacific Outlook (USD Billion, 2018-2030)






    • Asia-Pacific Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Asia-Pacific Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Asia-Pacific Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • China Outlook (USD Billion, 2018-2030)


    • China Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • China Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • China Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Japan Outlook (USD Billion, 2018-2030)


    • Japan Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Japan Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Japan Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • India Outlook (USD Billion, 2018-2030)


    • India Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • India Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • India Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Australia Outlook (USD Billion, 2018-2030)


    • Australia Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Australia Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Australia Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)


    • Rest of Asia-Pacific Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Rest of Asia-Pacific Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Rest of Asia-Pacific Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy





  • Rest of the World Outlook (USD Billion, 2018-2030)






    • Rest of the World Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Rest of the World Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Rest of the World Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Middle East Outlook (USD Billion, 2018-2030)


    • Middle East Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Middle East Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Middle East Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Africa Outlook (USD Billion, 2018-2030)


    • Africa Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Africa Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Africa Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy




    • Latin America Outlook (USD Billion, 2018-2030)


    • Latin America Human Insulin by Fusion Type

      • Analogue Insulin

      • Traditional Human Insulin




    • Latin America Human Insulin by Diabetes Type

      • Diabetes 1

      • Diabetes 2




    • Latin America Human Insulin by Distribution Channel

      • Hospital Pharmacy

      • Retail & Online Pharmacy





Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

5 Market Factor Analysis

5.1 Porterโ€™s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

6 Human Insulin Market, by Type

6.1 Introduction

6.2 Traditional Human Insulin

6.2.1 Premixed Traditional

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.2.2 Intermediate Acting

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.2.3 Short Acting

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.3 Modern Human Insulin

6.3.1 Premixed Modern

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.3.2 Long Acting

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

6.3.3 Rapid Acting

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7 Human Insulin Market, by Brand

7.1 Introduction

7.2 Lantus

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.3 Novorapid

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.4 Humalog

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.5 Novomix

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.6 Levemir

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.7 Apidar

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.8 Humulin

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

7.9 Insuman

Market Estimates & Forecast, by Region, 2023โ€“2030

Market Estimates & Forecast, by Country, 2023โ€“2030

8 Global Human Insulin Market, by Region

8.1 Introduction

8.2 Americas

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.1 North America

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.1.1 US

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.1.2 Canada

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.2 South America

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3 Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1 Western Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.1 Germany

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.2 France

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.3 Italy

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.4 Spain

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.5 UK

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.6 Rest of Western Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.2 Eastern Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4 Asia-Pacific

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.1 Japan

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.2 China

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.3 India

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.4 Australia

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.5 South Korea

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.6 Rest of Asia-Pacific

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.5 Middle East & Africa

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.5.1 Middle East

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.5.2 Africa

Human Insulin Market, by Type

Human Insulin Market, by Brand

9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

10 Company Profiles

10.1 ADOCIA

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 MERCK & CO., INC.

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Julphar

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Pfizer Inc.

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Bristol-Myers Squibb Company

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 GLAXOSMITHKLINE PLC

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 SANOFI

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Oramed

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Novo Nordisk India Pvt. Ltd

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Eli Lilly and Company

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 BIOCON

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.12 Tonghua Dongbao Pharmaceutical Co., Ltd

10.12.1 Overview

10.12.2 Product Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

10.13 Others

11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEOโ€™s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the global Human Insulin market

12 Appendix

13 LIST OF TABLES

Table 1 Human Insulin Market Synopsis, 2023โ€“2030

Table 2 Human Insulin Market Estimates and Forecast, 2023โ€“2030 (USD Million)

Table 3 Global Human Insulin Market, by Region, 2023โ€“2030 (USD Million)

Table 4 Global Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 5 Global Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 6 North America: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 7 North America: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 8 US: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 9 US: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 10 Canada: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 11 Canada: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 12 South America: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 13 South America: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 14 Europe: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 15 Europe: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 16 Western Europe: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 17 Western Europe: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 18 Eastern Europe: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 19 Eastern Europe: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 20 Asia-Pacific: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 21 Asia-Pacific: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

Table 22 Middle East & Africa: Human Insulin Market, by Type, 2023โ€“2030 (USD Million)

Table 23 Middle East & Africa: Human Insulin Market, by Brand, 2023โ€“2030 (USD Million)

14 LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Human Insulin Market

Figure 3 Market Dynamics for Global Human Insulin Market

Figure 4 Human Insulin Market Share, by Type, 2023

Figure 5 Human Insulin Market Share, by Brand, 2023

Figure 6 Human Insulin Market Share, by Region, 2023

Figure 7 North America: Human Insulin Market Share, by Country, 2023

Figure 8 Europe: Human Insulin Market Share, by Country, 2023

Figure 9 Asia-Pacific: Human Insulin Market Share, by Country, 2023

Figure 10 Middle East & Africa: Human Insulin Market Share, by Region, 2023

Figure 11 Human Insulin Market: Company Share Analysis, 2023 (%)

Figure 12 ADOCIA: Key Financials

Figure 13 ADOCIA: Segmental Revenue

Figure 14 ADOCIA: Geographical Revenue

Figure 15 MERCK & CO., INC.: Key Financials

Figure 16 MERCK & CO., INC.: Segmental Revenue

Figure 17 MERCK & CO., INC.: Geographical Revenue

Figure 18 Julphar: Key Financials

Figure 19 Julphar: Segmental Revenue

Figure 20 Julphar: Geographical Revenue

Figure 21 Pfizer Inc.: Key Financials

Figure 22 Pfizer Inc.: Segmental Revenue

Figure 23 Pfizer Inc.: Geographical Revenue

Figure 24 Bristol-Myers Squibb Company: Key Financials

Figure 25 Bristol-Myers Squibb Company: Segmental Revenue

Figure 26 Bristol-Myers Squibb Company: Geographical Revenue

Figure 27 GLAXOSMITHKLINE PLC: Key Financials

Figure 28 GLAXOSMITHKLINE PLC: Segmental Revenue

Figure 29 GLAXOSMITHKLINE PLC: Geographical Revenue

Figure 30 Oramed: Key Financials

Figure 31 Oramed: Segmental Revenue

Figure 32 Oramed: Geographical Revenue

Figure 33 Novo Nordisk India Pvt Ltd: Key Financials

Figure 34 Novo Nordisk India Pvt Ltd: Segmental Revenue

Figure 35 Novo Nordisk India Pvt Ltd: Geographical Revenue

Figure 36 Eli Lilly and Company: Key Financials

Figure 37 Eli Lilly and Company: Segmental Revenue

Figure 38 Eli Lilly and Company: Geographical Revenue

Figure 39 SANOFI: Key Financials

Figure 40 SANOFI: Segmental Revenue

Figure 41 SANOFI: Geographical Revenue

Figure 42 BIOCON: Key Financials

Figure 43 BIOCON: Segmental Revenue

Figure 44 BIOCON: Geographical Revenue

Figure 45 Tonghua Dongbao Pharmaceutical Co., Ltd.: Key Financials

Figure 46 Tonghua Dongbao Pharmaceutical Co., Ltd.: Segmental Revenue

Figure 47 Tonghua Dongbao Pharmaceutical Co., Ltd.: Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.